Discover What Financial Markets Can Do For You

Credibility, Competitive Advantage, New Business

EXPLORE OUR LATEST ANALYSIS

Unilever-McCormick $44 Bn Deal: Antitrust and Financial Analysis

On 31 March 2026, McCormick & Company and Unilever announced a definitive…

CMA’s Veterinary Remedies Bring New Risks for Private Equity Portfolios

The Competition and Markets Authority (CMA) has concluded its extensive investigation into…

The Deutsche Börse-Allfunds Remedy Plan: Openness, Data Neutrality, and Euroclear

Deutsche Börse is playing the Savings and Investments Union (SIU) card to…

Antitrust Implications of Four Financial Red Flags in the PSKY-WBD Merger

While the headline $31-per-share cash offer is designed to appease WBD stockholders,…

FINANCE FOR ANTITRUST LAWYERS

The Rise of Private Capital in Europe: Part Three

The "Deal Engine" Mindset and the Language of IRR In the first two parts of…

How to Turn a Redacted Merger Decision into a Usable Precedent

Imagine you are researching precedents for an important case and find a decision that seems…

The Compounding Effect of a Cartel: More than “Just” Higher Prices

When firms collude on price, they’re not just overcharging customers. They’re also reshaping revenue, profits,…

When Capital Injections Raise Regulatory Red Flags

A capital increase is when a company issues new shares to raise additional equity from…

Want to receive push notifications for all major on-site activities?